Anti-Glutamic Acid Decarboxylase-Associated Autoimmune Encephalitis Presenting as Presumed Herpes Simplex Viral Encephalitis in a Patient With Type 1 Diabetes Mellitus: A Case Report
Year: 2026
Type: article
Study design: Case Report
Abstract: A 68-year-old man presents with acute confusion, fevers, and new-onset seizures on the background of established type 1 diabetes mellitus (T1DM) and chronic Hashimoto's thyroiditis.An MRI scan identifies right-predominant multifocal T2/FLAIR hyperintense lesions involving the temporal, frontal, and parietal lobes without diffusion restriction.The patient was treated for presumptive herpes simplex virus encephalitis (HSE) with empiric antiviral therapy and clinically improved.Cerebrospinal fluid (CSF) subsequently returned strongly positive for anti-glutamic acid decarboxylase (anti-GAD) antibodies, with a negative extended viral panel.He was discharged home but re-presented two months later with progressive seizures, confusion, memory impairment, and interval progression of his MRI T2/FLAIR lesions, continuing to deteriorate despite broad-spectrum antimicrobial therapy.A diagnosis of anti-GAD-associated autoimmune encephalitis (AE) was established, and he made a rapid neurological recovery following initiation of immunosuppressive therapy.This case explores the diagnostic challenge of identifying anti-GAD-associated AE in the context of pre-existing T1DM, where elevated anti-GAD antibodies are not atypical, and highlights the importance of maintaining a broad differential in patients with autoimmune polyglandular disease presenting with encephalopathy.
Source: Cureus
Institutions: Royal Prince Alfred Hospital, Bankstown Lidcombe Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7225991277
